Activating mutations in PIK3CA, the PI3K 110α-encoding gene, have been identified in approximately 20% of patients with endometroid and clear-cell carcinoma, indicating that the PI3K/AKT/mTOR pathway plays a crucial role in OC [16]. The gene discussed is PIK3CB; the disease is clear cell adenocarcinoma.